Tandem Diabetes Care reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Tandem Diabetes Care using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.36 | $-0.40 | 10.0 % |
Jun 2024 | 2024-08-01 | $-0.48 | $-0.54 | 11.1 % |
Mar 2024 | 2024-05-02 | $-0.64 | $-0.76 | 15.8 % |
Dec 2023 | 2024-02-21 | $-0.27 | $-0.25 | -8.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $243.97M | $223.66M | 9.08 % |
Jun 2024 | 2024-08-01 | $221.91M | $205.63M | 7.92 % |
Mar 2024 | 2024-05-02 | $191.67M | $173.92M | 10.2 % |
Dec 2023 | 2024-02-21 | $196.80M | $203.41M | -3.25 % |
Tandem Diabetes Care (TNDM) is scheduled to report earnings on February 19, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.36, which beat the estimate of $-0.40.
The Actual Revenue was $244M, which beat the estimate of $223.7M.
Browse earnings estimates, EPS, and revenue on all stocks.